+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Head & Neck Cancer Diagnostics Market Research Report by Diagnostic Method, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 235 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5456878
UP TO OFF until Dec 31st 2022
The Global Head & Neck Cancer Diagnostics Market size was estimated at USD 1,283.21 million in 2021, USD 1,494.94 million in 2022, and is projected to grow at a CAGR of 16.67% to reach USD 3,237.50 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Head & Neck Cancer Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Diagnostic Method, the market was studied across Bioscopy Screening, Blood Tests, Dental Diagnostic, Diagnostic Imaging, and Endoscopy Screening.
  • Based on End User, the market was studied across Diagnostic Centers, Hospitals, and Other.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Head & Neck Cancer Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Head & Neck Cancer Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Head & Neck Cancer Diagnostics Market, including Addent, Inc., Fujifilm Holdings, GE Healthcare, Hitachi Medical, Identafi, Neusoft, Philips Healthcare, Siemens Healthcare, Toshiba, and Varian Medical Systems.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Head & Neck Cancer Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Head & Neck Cancer Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Head & Neck Cancer Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Head & Neck Cancer Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Head & Neck Cancer Diagnostics Market?
6. What is the market share of the leading vendors in the Global Head & Neck Cancer Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Head & Neck Cancer Diagnostics Market?
Frequently Asked Questions about the Global Head & Neck Cancer Diagnostics Market

What is the estimated value of the Global Head & Neck Cancer Diagnostics Market?

The Global Head & Neck Cancer Diagnostics Market was estimated to be valued at $1283.21 Million in 2021.

What is the growth rate of the Global Head & Neck Cancer Diagnostics Market?

The growth rate of the Global Head & Neck Cancer Diagnostics Market is 16.6%, with an estimated value of $3237.5 Million by 2027.

What is the forecasted size of the Global Head & Neck Cancer Diagnostics Market?

The Global Head & Neck Cancer Diagnostics Market is estimated to be worth $3237.5 Million by 2027.

Who are the key companies in the Global Head & Neck Cancer Diagnostics Market?

Key companies in the Global Head & Neck Cancer Diagnostics Market include Addent, Inc., Fujifilm Holdings, GE Healthcare, Hitachi Medical, Identafi, Neusoft, Philips Healthcare, Siemens Healthcare and Varian Medical Systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of diagnostic procedures for head and neck cancer
5.1.1.2. Rise in government and private body initiatives for cancer diagnostic
5.1.1.3. Rising human healthcare expenditure and increasing demand for diagnostic imaging
5.1.2. Restraints
5.1.2.1. High cost of the devices and unfavourable reimbursement scenarios
5.1.3. Opportunities
5.1.3.1. New advancements and innovations in diagnostic methodology
5.1.3.2. Large research funding in oncological advancement
5.1.4. Challenges
5.1.4.1. Dearth of trained professionals
5.2. Cumulative Impact of COVID-19
6. Head & Neck Cancer Diagnostics Market, by Diagnostic Method
6.1. Introduction
6.2. Bioscopy Screening
6.3. Blood Tests
6.4. Dental Diagnostic
6.5. Diagnostic Imaging
6.6. Endoscopy Screening
7. Head & Neck Cancer Diagnostics Market, by End User
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
7.4. Other
8. Americas Head & Neck Cancer Diagnostics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Head & Neck Cancer Diagnostics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Head & Neck Cancer Diagnostics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Addent, Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Fujifilm Holdings
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. GE Healthcare
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Hitachi Medical
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Identafi
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Neusoft
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Philips Healthcare
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Siemens Healthcare
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Toshiba
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Varian Medical Systems
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2021 VS 2027 (%)
FIGURE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DIAGNOSTIC METHOD, 2027
FIGURE 14. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 20. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 22. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, 2018-2027 (USD MILLION)
FIGURE 25. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 27. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 28. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 29. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 35. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 37. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 39. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 40. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 41. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 57. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 79. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 80. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 34. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 35. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 36. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 38. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 39. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 41. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 42. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 44. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 45. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 47. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 48. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 50. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 51. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 56. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 58. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 59. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 61. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 62. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 64. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 65. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 67. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 68. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 69. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 70. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 71. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 72. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 73. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 74. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 75. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 76. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 77. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 78. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 79. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 80. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 81. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 82. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 83. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 85. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 86. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 88. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 89. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 90. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 91. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 96. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 97. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 98. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 99. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 101. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 102. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 104. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 105. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 106. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 107. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 108. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 109. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 110. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 111. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 113. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 114. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 116. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 117. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 119. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 120. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 122. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 123. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 125. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 126. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 128. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 129. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 131. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 132. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 134. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 135. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 137. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 138. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 140. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 141. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 143. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 144. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 146. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 147. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 149. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 150. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 151. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 152. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 156. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2027 (USD MILLION)
TABLE 158. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 159. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 160. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 161. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 162. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 163. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 164. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET MERGER & ACQUISITION
TABLE 165. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 166. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 167. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET INVESTMENT & FUNDING
TABLE 168. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 169. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Addent, Inc.
  • Fujifilm Holdings
  • GE Healthcare
  • Hitachi Medical
  • Identafi
  • Neusoft
  • Philips Healthcare
  • Siemens Healthcare
  • Toshiba
  • Varian Medical Systems

Methodology

Loading
LOADING...